Different dosage schedules for reducing cardiotoxicity in cancer patients receiving anthracycline chemotherapy has been found in Evidence-Based Medicine Guidelines

If you are a registered user, please login below.

If not, learn more about gaining full access.

Login

User Name:

Password:

Forgot your password?

Forgot your username?

Remember Me

Try

Evidence Central Online™ is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research.

View these topics online FREE

• Aseptic bursitis of the elbow
• Aortic stenosis
• First-line drugs for hypertension
• Antioxidants may increase mortality